Cargando…

Prediction of Mutational Tolerance in HIV-1 Protease and Reverse Transcriptase Using Flexible Backbone Protein Design

Predicting which mutations proteins tolerate while maintaining their structure and function has important applications for modeling fundamental properties of proteins and their evolution; it also drives progress in protein design. Here we develop a computational model to predict the tolerated sequen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Humphris-Narayanan, Elisabeth, Akiva, Eyal, Varela, Rocco, Ó Conchúir, Shane, Kortemme, Tanja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426558/ https://www.ncbi.nlm.nih.gov/pubmed/22927804 http://dx.doi.org/10.1371/journal.pcbi.1002639

Ejemplares similares

RosettaBackrub—a web server for flexible backbone protein structure modeling and design
por: Lauck, Florian, et al.
Publicado: (2010)

Predicting the Tolerated Sequences for Proteins and Protein Interfaces Using RosettaBackrub Flexible Backbone Design
por: Smith, Colin A., et al.
Publicado: (2011)

Coupling Protein Side-Chain and Backbone Flexibility Improves the Re-design of Protein-Ligand Specificity
por: Ollikainen, Noah, et al.
Publicado: (2015)

Design of Multi-Specificity in Protein Interfaces
por: Humphris, Elisabeth L, et al.
Publicado: (2007)

Development of Elvitegravir Resistance and Linkage of Integrase Inhibitor Mutations with Protease and Reverse Transcriptase Resistance Mutations
por: Winters, Mark A., et al.
Publicado: (2012)

HIV-1 Protease, Reverse Transcriptase, and Integrase Variation
por: Rhee, Soo-Yon, et al.
Publicado: (2016)

Structural and Functional Aspects of Foamy Virus Protease-Reverse Transcriptase
por: Wöhrl, Birgitta M.
Publicado: (2019)

Structures of Substrate Complexes of Foamy Viral Protease-Reverse Transcriptase
por: Nowacka, Marzena, et al.
Publicado: (2021)

HIV-1 Phenotypic Reverse Transcriptase Inhibitor Drug Resistance Test Interpretation Is Not Dependent on the Subtype of the Virus Backbone
por: Bronze, Michelle, et al.
Publicado: (2012)

HIV-1 Protease and Reverse Transcriptase Control the Architecture of Their Nucleocapsid Partner
por: Mirambeau, Gilles, et al.
Publicado: (2007)

HIV-1 Protease and Reverse Transcriptase Control the Architecture of Their Nucleocapsid Partner
Publicado: (2014)

HIV-1 Subtype B Protease and Reverse Transcriptase Amino Acid Covariation
por: Rhee, Soo-Yon, et al.
Publicado: (2007)

Mutations in the Reverse Transcriptase and Protease Genes of Human Immunodeficiency Virus-1 from Antiretroviral Naïve and Treated Pediatric Patients
por: Bure, Dinesh, et al.
Publicado: (2015)

Reverse transcriptase and protease inhibitors mutational viral load in HIV infected pregnant women with transmitted drug resistance in Argentina
por: Cecchini, Diego, et al.
Publicado: (2021)

Mutation Rates and Intrinsic Fidelity of Retroviral Reverse Transcriptases
por: Menéndez-Arias, Luis
Publicado: (2009)

Drug Resistance Mutations Against Protease, Reverse Transcriptase and Integrase Inhibitors in People Living With HIV-1 Receiving Boosted Protease Inhibitors in South Africa
por: Obasa, Adetayo Emmanuel, et al.
Publicado: (2020)

Polymorphisms in reverse transcriptase and protease genes of HIV-1 subtype C from Mumbai
por: Dahake, Ritwik, et al.
Publicado: (2014)

Sequence and structure based models of HIV-1 protease and reverse transcriptase drug resistance
por: Masso, Majid, et al.
Publicado: (2013)

Binding interface and impact on protease cleavage for an RNA aptamer to HIV-1 reverse transcriptase
por: Nguyen, Phuong D M, et al.
Publicado: (2020)

Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq
por: Dudley, Dawn M, et al.
Publicado: (2014)

HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals
por: Bokharaei-Salim, Farah, et al.
Publicado: (2020)

Genetic and antiretroviral drug resistance mutations analysis of reverse transcriptase and protease gene from Pakistani people living with HIV-1
por: Siddiqui, Dilsha, et al.
Publicado: (2023)

Altered expression of a quality control protease in E. coli reshapes the in vivo mutational landscape of a model enzyme
por: Thompson, Samuel, et al.
Publicado: (2020)

Estimating the Fitness Cost of Escape from HLA Presentation in HIV-1 Protease and Reverse Transcriptase
por: Mostowy, Rafal, et al.
Publicado: (2012)

A Web Resource for Standardized Benchmark Datasets, Metrics, and Rosetta Protocols for Macromolecular Modeling and Design
por: Ó Conchúir, Shane, et al.
Publicado: (2015)

A Partially Multiplexed HIV Drug Resistance (HIVDR) Assay for Monitoring HIVDR Mutations of the Protease, Reverse-Transcriptase (PRRT), and Integrase (INT)
por: DeVos, Joshua, et al.
Publicado: (2022)

A reverse transcriptase ribozyme
por: Samanta, Biswajit, et al.
Publicado: (2017)

Data driven flexible backbone protein design
por: Sun, Mark G. F., et al.
Publicado: (2017)

Reverse transcriptase activity in psoriatic lesions: effects of reverse transcriptase inhibitors on keratinocyte proliferation and differentiation
por: Molès, Jean-Pierre, et al.
Publicado: (2009)

Clinical Significance of Telomerase Reverse-Transcriptase Promoter Mutations in Hepatocellular Carcinoma
por: Pezzuto, Francesca, et al.
Publicado: (2021)

Influence of Human Telomerase Reverse Transcriptase Mutation on the Aggressiveness and Recurrence in Meningiomas
por: Sahin, Balkan, et al.
Publicado: (2021)

Distinguishing Functional Amino Acid Covariation from Background Linkage Disequilibrium in HIV Protease and Reverse Transcriptase
por: Wang, Qi, et al.
Publicado: (2007)

Crystal Structure of a Retroviral Polyprotein: Prototype Foamy Virus Protease-Reverse Transcriptase (PR-RT)
por: Harrison, Jerry Joe E. K., et al.
Publicado: (2021)

Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability
por: Usach, Iris, et al.
Publicado: (2013)

Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana
por: Moyo, Sikhulile, et al.
Publicado: (2019)

Comparison of the Effects of Three Dual-Nucleos(t)ide Reverse Transcriptase Inhibitor Backbones on Placenta Mitochondria Toxicity and Oxidative Stress Using a Mouse Pregnancy Model
por: Balogun, Kayode, et al.
Publicado: (2022)

Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration
por: Kantor, Rami, et al.
Publicado: (2005)

Coevolved Multidrug-Resistant HIV-1 Protease and Reverse Transcriptase Influences Integrase Drug Susceptibility and Replication Fitness
por: Martin, Supang A., et al.
Publicado: (2021)

Affordable drug resistance genotyping of HIV-1 reverse transcriptase, protease and integrase genes, for resource limited settings
por: Manyana, Sontaga, et al.
Publicado: (2023)

Telomerase reverse transcriptase and neurodegenerative diseases
por: Yu, Xin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q7a5mv2aglfe3fjr7rd9kdki2d